Competitive pressures prompt Truist to cut Insmed (INSM) target
With a 5-year average revenue growth rate of 23.8%, Insmed Incorporated (NASDAQ:INSM) is included among the The 11 Best Long-Term US Stocks to Buy Right Now. Competitive pressures prompt Truist to cut Insmed (INSM) target On May 13, Truist lowered the company’s price target on Insmed Incorporated (NASDAQ:INSM) to $185 from $205, while maintaining a…